Sauder Schelkopf is currently investigating potential legal claims regarding serious vision-related side effects associated with the use of popular weight loss and diabetes medications, including Ozempic and Wegovy. Recent reports and emerging medical studies have raised concerns about a potential link between semaglutide (the active ingredient in these drugs) and severe eyesight complications, including vision loss.
A 2020 FDA study documented over 140 cases of adverse vision effects related to semaglutide use. More recently, a July 2024 study published in JAMA Ophthalmology identified cases of non-arteritic anterior ischemic optic neuropathy (NAION) among patients using these medications. A January 2025 follow-up study further underscored these concerns, warning of a possible connection between rapid blood sugar corrections and severe eye conditions.
If you have suffered vision impairment after taking these medications, we encourage you to contact the attorneys at Sauder Schelkopf.
Experience Matters
Sauder Schelkopf has a nationally recognized litigation practice. The firm currently serves as court-appointed lead counsel in courts across the country. The attorneys at Sauder Schelkopf have recovered over $1 billion on behalf of their clients and class members. Our firm was recognized by the Legal Intelligencer’s 2022 Professional Excellence Awards. The Legal Intelligencer’s Professional Excellence Awards honor Pennsylvania law firms and attorneys who have made a significant, positive impact on the legal profession. Our firm was named in the Litigation Departments of the Year (Specialty Area category; runner-up), an award that honors the best litigation practice in a small or mid-sized firm in Pennsylvania. This recognition was based on the firm’s 2021 litigation work and its important ongoing cases. LawDragon has recognized our attorneys in its list of the “500 Leading Plaintiff Consumer Lawyers” for 2022. This list notes: “From the opioid epidemic to toxic substances and defective products, truck accidents to wildfires and sexual abuse, these are the lawyers who stand on the front line in individual lawsuits and class actions seeking justice.” Mr. Schelkopf was named to Pennsylvania’s Best Lawyers® 2022 for Class Actions/Mass Tort Litigation. The American Lawyer named Mr. Sauder to its 2021 Northeast Trailblazers. The honor recognizes 60 lawyers who are “truly agents of change.” It “recognizes professionals in the Northeast who have moved the needle in the legal industry.” The Legal Intelligencer named Mr. Sauder and Mr. Schelkopf in its 2020 Pennsylvania Trailblazers list recognizing 31 lawyers who “have taken extra measures to contribute to positive outcomes . . . and who are truly agents of change.” The Legal highlighted the firm’s innovative work on advocacy as class counsel in large institutional sex abuse cover-ups, women’s, and children’s rights. Our attorneys have also consistently been recognized by their peers being named to Pennsylvania SuperLawyer, a distinction held by the top 5% of attorneys in Pennsylvania. The National Trial Lawyers Association has also selected our attorneys as the Top 100 Trial Lawyers in Pennsylvania.
We Want to Hear from You
If you have suffered vision impairment after taking these medications, we encourage you to contact the attorneys at Sauder Schelkopf.